Assessing incremental value of biomarkers with multi-phase nested case-control studies
DOI10.1111/biom.12344zbMath1419.62495OpenAlexW1490191373WikidataQ36761375 ScholiaQ36761375MaRDI QIDQ2809548
Tianxi Cai, Yingye Zheng, Qian M. Zhou, Elizabeth W. Karlson, Lori B. Chibnik
Publication date: 30 May 2016
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc4819437
incremental valuerisk predictioninverse probability weightingnested case-control studyrheumatoid arthritistime dependent ROC curve analysis
Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in survival analysis and censored data (62N02)
Related Items (2)
Cites Work
- Weighted analyses for cohort sampling designs
- Asymptotic theory for nested case-control sampling in the Cox regression model
- Evaluating prognostic accuracy of biomarkers in nested case-control studies
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
- Retrospective studies and failure time models
- A pseudolikelihood approach to analysis of nested case-control studies
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
- Evaluating Prediction Rules fort-Year Survivors With Censored Regression Models
- Resampling Procedures for Making Inference Under Nested Case–Control Studies
This page was built for publication: Assessing incremental value of biomarkers with multi-phase nested case-control studies